Actos is the brand name for the drug pioglitazone. The FDA approved the drug in 1999 for use in the treatment of Type II diabetes, the most common form of diabetes in North America.
Pioglitazone is also sold as:
- Actoplus Met (pioglitazone combined with another diabetes medication called “metformin”)
- Actoplus Met XR (extended release)
- Duetact (pioglitazone combined with the diabetes medication glimepiride).